Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 14, 2018; 24(10): 1120-1133
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1120
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1120
Figure 7 Proteinase-activated receptor 2 mediates the activation of ERK and further induces epithelial-mesenchymal transition.
A: The protein levels of ERK and p-ERK in HepG2 and SMMC-7721 cells; B: The morphological changes in HepG2 and SMMC-7721 cells after proteinase-activated receptor 2 knockdown; C and D: The protein levels of EGR-1, Snail, E-cadherin, and N-cadherin in HepG2 and SMMC-7721 cells. GAPDH was selected as an endogenous control.
- Citation: Sun L, Li PB, Yao YF, Xiu AY, Peng Z, Bai YH, Gao YJ. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2018; 24(10): 1120-1133
- URL: https://www.wjgnet.com/1007-9327/full/v24/i10/1120.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i10.1120